BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31310815)

  • 1. A Comparison of Patient-Reported Health-Related Quality of Life During Proton Versus Photon Chemoradiation Therapy for Esophageal Cancer.
    Garant A; Whitaker TJ; Spears GM; Routman DM; Harmsen WS; Wilhite TJ; Ashman JB; Sio TT; Rule WG; Neben Wittich MA; Martenson JA; Tryggestad EJ; Yoon HH; Blackmon S; Merrell KW; Haddock MG; Hallemeier CL
    Pract Radiat Oncol; 2019 Nov; 9(6):410-417. PubMed ID: 31310815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comparison of Grade 4 Lymphopenia With Proton Versus Photon Radiation Therapy for Esophageal Cancer.
    Routman DM; Garant A; Lester SC; Day CN; Harmsen WS; Sanheuza CT; Yoon HH; Neben-Wittich MA; Martenson JA; Haddock MG; Hallemeier CL; Merrell KW
    Adv Radiat Oncol; 2019; 4(1):63-69. PubMed ID: 30706012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-Reported Quality of Life Before and After Chemoradiation for Intact Pancreas Cancer: A Prospective Registry Study.
    Breen WG; Jethwa KR; Yu NY; Spears GM; Harmsen WS; Miller RC; Ashman JB; Rule WG; Sio TT; Neben-Wittich MA; Haddock MG; Mahipal A; Truty MJ; Hallemeier CL; Merrell KW
    Pract Radiat Oncol; 2021; 11(1):e63-e69. PubMed ID: 32712461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superior Intellectual Outcomes After Proton Radiotherapy Compared With Photon Radiotherapy for Pediatric Medulloblastoma.
    Kahalley LS; Peterson R; Ris MD; Janzen L; Okcu MF; Grosshans DR; Ramaswamy V; Paulino AC; Hodgson D; Mahajan A; Tsang DS; Laperriere N; Whitehead WE; Dauser RC; Taylor MD; Conklin HM; Chintagumpala M; Bouffet E; Mabbott D
    J Clin Oncol; 2020 Feb; 38(5):454-461. PubMed ID: 31774710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Health-Related Quality of Life in Patients With Rectal Cancer After Preoperative Short-Course and Long-Course (Chemo) Radiotherapy.
    Wiltink LM; Nout RA; van der Voort van Zyp JR; Ceha HM; Fiocco M; Meershoek-Klein Kranenbarg E; Marinelli AW; van de Velde CJ; Marijnen CA
    Clin Colorectal Cancer; 2016 Sep; 15(3):e93-9. PubMed ID: 26968237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life outcomes in proton and photon treated pediatric brain tumor survivors.
    Yock TI; Bhat S; Szymonifka J; Yeap BY; Delahaye J; Donaldson SS; MacDonald SM; Pulsifer MB; Hill KS; DeLaney TF; Ebb D; Huang M; Tarbell NJ; Fisher PG; Kuhlthau KA
    Radiother Oncol; 2014 Oct; 113(1):89-94. PubMed ID: 25304720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term cognitive and academic outcomes among pediatric brain tumor survivors treated with proton versus photon radiotherapy.
    Child AE; Warren EA; Grosshans DR; Paulino AC; Okcu MF; Ris MD; Mahajan A; Orobio J; Cirino PT; Minard CG; Viana AG; Bick J; Woods SP; Chintagumpala M; Kahalley LS
    Pediatr Blood Cancer; 2021 Sep; 68(9):e29125. PubMed ID: 34114294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Effectiveness of Proton vs Photon Therapy as Part of Concurrent Chemoradiotherapy for Locally Advanced Cancer.
    Baumann BC; Mitra N; Harton JG; Xiao Y; Wojcieszynski AP; Gabriel PE; Zhong H; Geng H; Doucette A; Wei J; O'Dwyer PJ; Bekelman JE; Metz JM
    JAMA Oncol; 2020 Feb; 6(2):237-246. PubMed ID: 31876914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
    Bradley JD; Paulus R; Komaki R; Masters G; Blumenschein G; Schild S; Bogart J; Hu C; Forster K; Magliocco A; Kavadi V; Garces YI; Narayan S; Iyengar P; Robinson C; Wynn RB; Koprowski C; Meng J; Beitler J; Gaur R; Curran W; Choy H
    Lancet Oncol; 2015 Feb; 16(2):187-99. PubMed ID: 25601342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Projected second tumor risk and dose to neurocognitive structures after proton versus photon radiotherapy for benign meningioma.
    Arvold ND; Niemierko A; Broussard GP; Adams J; Fullerton B; Loeffler JS; Shih HA
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e495-500. PubMed ID: 22285662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intellectual functioning among case-matched cohorts of children treated with proton or photon radiation for standard-risk medulloblastoma.
    Eaton BR; Fong GW; Ingerski LM; Pulsifer MB; Goyal S; Zhang C; Weyman EA; Esiashvili N; Klosky JL; MacDonald TJ; Ebb DH; MacDonald SM; Tarbell NJ; Yock TI
    Cancer; 2021 Oct; 127(20):3840-3846. PubMed ID: 34255345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothyroidism after craniospinal irradiation with proton or photon therapy in patients with medulloblastoma.
    Bielamowicz K; Okcu MF; Sonabend R; Paulino AC; Hilsenbeck SG; Dreyer Z; Suzawa H; Bryant R; Adesina A; Dauser R; Mahajan A; Chintagumpala M
    Pediatr Hematol Oncol; 2018 May; 35(4):257-267. PubMed ID: 30537887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton radiation therapy (PRT) for pediatric optic pathway gliomas: comparison with 3D planned conventional photons and a standard photon technique.
    Fuss M; Hug EB; Schaefer RA; Nevinny-Stickel M; Miller DW; Slater JM; Slater JD
    Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1117-26. PubMed ID: 10613303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical Trial.
    Movsas B; Hu C; Sloan J; Bradley J; Komaki R; Masters G; Kavadi V; Narayan S; Michalski J; Johnson DW; Koprowski C; Curran WJ; Garces YI; Gaur R; Wynn RB; Schallenkamp J; Gelblum DY; MacRae RM; Paulus R; Choy H
    JAMA Oncol; 2016 Mar; 2(3):359-67. PubMed ID: 26606200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of dosimetric parameters and toxicity in esophageal cancer patients undergoing 3D conformal radiotherapy or VMAT.
    Münch S; Aichmeier S; Hapfelmeier A; Duma MN; Oechsner M; Feith M; Combs SE; Habermehl D
    Strahlenther Onkol; 2016 Oct; 192(10):722-9. PubMed ID: 27418129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-treatment neuroendocrine outcomes among pediatric brain tumor patients: Is there a difference between proton and photon therapy?
    Yip AT; Yu JD; Huynh-Le MP; Salans M; Unnikrishnan S; Qian AS; Xu R; Kaner R; MacEwan I; Crawford JR; Hattangadi-Gluth JA
    Clin Transl Radiat Oncol; 2022 May; 34():37-41. PubMed ID: 35345865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved neuropsychological outcomes following proton therapy relative to X-ray therapy for pediatric brain tumor patients.
    Gross JP; Powell S; Zelko F; Hartsell W; Goldman S; Fangusaro J; Lulla RR; Smiley NP; Chang JH; Gondi V
    Neuro Oncol; 2019 Jul; 21(7):934-943. PubMed ID: 30997512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes.
    Shao MS; Wong AT; Schwartz D; Weiner JP; Schreiber D
    Ann Thorac Surg; 2016 Jun; 101(6):2148-54. PubMed ID: 27016842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy.
    Chera BS; Rodriguez C; Morris CG; Louis D; Yeung D; Li Z; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1173-80. PubMed ID: 19386423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation field size and dose determine oncologic outcome in esophageal cancer.
    Gemici C; Yaprak G; Batirel HF; Ilhan M; Mayadagli A
    World J Surg Oncol; 2016 Oct; 14(1):263. PubMed ID: 27737673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.